Novartis Canada is pleased to announce that Scemblix® (asciminib) is one of the first therapies to be prioritized for public reimbursement under Ontario's new Funding Accelerated for Specific ...

By the end of 3 induction cycles, the best minimal residual disease (MRD) negativity rate and the MRD-negative complete ...

Molecular responses continue to deepen with extended treatment duration, reaching 60% major molecular response at 21 cycles ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical ...

Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, ...

Using CD22/CD19 CAR T-cell therapy followed by autologous stem cell transplant (ASCT) showed promising results in patients ...

Much of the archipelago’s undersea splendor is protected, but some areas are being stressed by climate change and harmed by destructive fishing practices. Tourists swim with whale sharks near Oslob, ...

A chemotherapy-free regimen significantly improved outcomes compared with standard therapy for newly diagnosed Ph+ acute ...

A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. The Phase III trial ...

RICHMOND, Va., Nov. 24, 2025 /PRNewswire/ -- As part of National Pancreas Awareness Month, VCU Health Hume-Lee Transplant Center is spotlighting its nationally recognized expertise in Total ...

Artificial intelligence (AI) can now tell whether someone may have chronic stress by looking at routine medical scans, according to a new study. Using a deep learning AI model to analyse routine chest ...